Table 1.
The complete information of the all 35 patients, including imaging results, pathology results, and surgical outcome.
| No. | Sex | Age(y) | MRI | SPM-PET | 3D-SSP | Visual-PET | PEZ | Surgery | Pathology | Engel |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 28 | N | L T | L T | L T | L T | L ant_T resection | HS/m_T ulegyria | I |
| 2 | M | 24 | N | L T | L T | L T | L T | L ant_T resection | HS/m_T FCD | I |
| 3 | M | 24 | L T–P–O | L T–P–O (FDR) | L T–P–O | L T–P–O | L T–P–O | L T–P–O lesion resection | FCD | II |
| 4 | M | 6 | R T | R T | R T | R T | R T | R ant_T resection | HS/m_T sclerosis | I |
| 5 | M | 44 | N | R O | R T | R T | R T | R ant_T resection | HS/m_T sclerosis | I |
| 6 | M | 24 | N | R T–P–O | R T–P–O | R P | R T–P–O | R T–P–O lesion resection | FCD | I |
| 7 | M | 31 | L T | L F | L F | L T | L T | L ant_T resection | HS/m_T sclerosis | I |
| 8 | M | 10 | R T | R T/T–O/F (FDR) | R T/T–O | R T/P/O | R T | R post_T resection | encephalitis | IV |
| 9 | M | 20 | N | R T | R T | R T | R T | R ant_T resection | HS/m_T sclerosis | I |
| 10 | F | 37 | L T | L T | L T | L T | L T | L ant_T resection | HS/m_T FCD | I |
| 11 | M | 38 | N | R T | R T | N | R T | R ant_T resection | HS/m_T sclerosis | I |
| 12 | M | 10 | R insular | R P/insular | R T–P–O | R P/T | R insular | R insular lesion resection | FCD | III |
| 13 | M | 18 | R F | R F/T | R T | R F/T | R T/F | R ant_T resection; R F lesion resection | FCD | II |
| 14 | F | 28 | L T | L T | L T | L T | L T | L ant_T resection | HS/m_T sclerosis | I |
| 15 | M | 38 | L T | L T | L T | L/R T | L T | L ant_T resection | HS/m_T sclerosis | I |
| 16 | M | 25 | N | R T | R T | R T | R T | R ant_T resection | HS/m_T FCD | I |
| 17 | M | 16 | N | L T | L T | L T | L T | L ant_T resection | HS/m_T sclerosis | III |
| 18 | M | 16 | N | N | N | R T | R T | R ant_T resection | HS/m_T FCD | I |
| 19 | M | 34 | L T | L T | L T | N | L T | L ant_T resection | HS/m_T sclerosis | I |
| 20 | F | 10 | N | R F/P/SMA (FDR) | DIFF | L/R cerebellum | R SMA | VNS | ||
| 21 | F | 10 | R T | L/R T (FDR) | L/R T | N | R/L T | VNS | ||
| 22 | M | 18 | L T | R T–P–O | L F | R F | R T | VNS | ||
| 23 | M | 10 | N | L/R cerebellum | L/R cerebellum | N | L/R cerebellum | VNS | ||
| 24 | M | 12 | L/R F | L/R cerebellum | L/R cerebellum | N | L/R cerebellum | VNS | ||
| 25 | M | 18 | N | DIFF | L/R cerebellum | N | L/R cerebellum | VNS | ||
| 26 | M | 29 | N | DIFF | DIFF | N | DIFF | VNS | ||
| 27 | F | 11 | N | L/R T | L/R T | N | L/R T | VNS | ||
| 28 | M | 21 | N | L/R cerebellum | L/R cerebellum | R F | L/R cerebellum | VNS | ||
| 29 | M | 25 | R T–P–O | R T–P–O | NONE | N | R primary motor | VNS | ||
| 31 | F | 28 | N | DIFF | DIFF | N | DIFF | AED | ||
| 32 | F | 24 | N | L T–P–O | N | N | L primary motor | AED | ||
| 32 | M | 22 | N | L F/P | DIFF | N | L primary motor | AED | ||
| 33 | M | 47 | N | DIFF | DIFF | N | DIFF | AED | ||
| 34 | F | 47 | N | DIFF | DIFF | N | DIFF | AED | ||
| 35 | M | 42 | N | R SMA/F | DIFF | N | R SMA | AED |
y, year; F, female; M, male; L, left; R, right; T, temporal lobe; P, parietal lobe; F, frontal lobe; O, occipital lobe; SMA, supplementary motor area; ant_T, anterior temporal lobe; post_T, posterior temporal lobe; m_T, medial temporal lobe; T–P–O, junction of temporal–parietal–occipital lobe; T–O, junction of temporal–occipital lobe; T/P/O, all temporal lobe, parietal lobe, and occipital lobe. DIFF, diffuse into multi-lobes; N, normal; VNS, vagus nerve stimulation; AED, antiepileptic drugs; HS, hippocampal sclerosis; FCD, focal cortical dysplasia. FDR, FDR corrected.